化学
他汀类
还原酶
辅酶A
阿托伐他汀
药理学
HMG-CoA还原酶
西伐他汀
肌痛
生物化学
酶
内科学
医学
作者
Ronald W. Sarver,Elizabeth Bills,Gary L. Bolton,Larry D. Bratton,Nicole L. Caspers,James B. Dunbar,Melissa S. Harris,R. H. Hutchings,Robert M. Kennedy,Scott D. Larsen,Alexander G. Pavlovsky,Jeffrey A. Pfefferkorn,Graeme Bainbridge
摘要
Clinical studies have demonstrated that statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) inhibitors, are effective at lowering mortality levels associated with cardiovascular disease; however, 2-7% of patients may experience statin-induced myalgia that limits compliance with a treatment regimen. High resolution crystal structures, thermodynamic binding parameters, and biochemical data were used to design statin inhibitors with improved HMGR affinity and therapeutic index relative to statin-induced myalgia. These studies facilitated the identification of imidazole 1 as a potent (IC 50 = 7.9 nM) inhibitor with excellent hepatoselectivity (>1000-fold) and good in vivo efficacy. The binding of 1 to HMGR was found to be enthalpically driven with a Delta H of -17.7 kcal/M. Additionally, a second novel series of bicyclic pyrrole-based inhibitors was identified that induced order in a protein flap of HMGR. Similar ordering was detected in a substrate complex, but has not been reported in previous statin inhibitor complexes with HMGR.
科研通智能强力驱动
Strongly Powered by AbleSci AI